REG - Bellevue Healthcare - Holding(s) in Company

Bellevue Healthcare TrustAnnouncement

12/03/2025 09:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250312:nRSL2726Aa&default-theme=true

RNS Number : 2726A  Bellevue Healthcare Trust PLC  12 March 2025

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BZCNLL95

Issuer Name

BELLEVUE HEALTHCARE TRUST PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of
financial instruments; An event changing the breakdown of voting rights

3. Details of person subject to the notification obligation

Name

Saba Capital Management, L.P.

City of registered office (if applicable)

New York

Country of registered office (if applicable)

United States

4. Details of the shareholder

 Name                                             City of registered office  Country of registered office
 Saba Capital Bluebird Fund, Ltd.                                            Cayman Islands
 Saba Capital Income & Opportunities Fund                                    United States
 Saba Capital CEF Opportunities 1, Ltd.                                      Cayman Islands
 Saba Capital CEF Opportunities 2, Ltd.                                      Cayman Islands
 Saba Capital Income & Opportunities Fund II                                 United States
 Stone Ridge Archimedes Sub-Master (Red) LP                                  United States
 I-94 Partners Fund LP                                                       United States
 Saba Capital Master Fund, Ltd.                                              Cayman Islands

5. Date on which the threshold was crossed or reached

10-Mar-2025

6. Date on which Issuer notified

11-Mar-2025

7. Total positions of person(s) subject to the notification obligation

                                                                            % of voting rights attached to shares (total of 8.A)  % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)  Total of both in % (8.A + 8.B)  Total number of voting rights held in issuer
 Resulting situation on the date on which threshold was crossed or reached  0.892245                                              11.187704                                                                  12.079949                       29270059
 Position of previous notification (if applicable)                          0.826109                                              10.650057                                                                  11.476166

8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached

8A. Voting rights attached to shares

 Class/Type of shares ISIN code(if possible)  Number of direct voting rights (DTR5.1)  Number of indirect voting rights (DTR5.2.1)  % of direct voting rights (DTR5.1)  % of indirect voting rights (DTR5.2.1)
 GB00BZCNLL95                                 2161936                                  0                                            0.892245                            0.000000
 Sub Total 8.A                                2161936                                                                               0.892245%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 Type of financial instrument  Expiration date  Exercise/conversion period  Number of voting rights that may be acquired if the instrument is  % of voting rights
                                                                            exercised/converted

 Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))

 Type of financial instrument  Expiration date  Exercise/conversion period  Physical or cash settlement  Number of voting rights  % of voting rights
 Total Return Swap             11/28/2025                                   Cash                         27108123                 11.187704
 Sub Total 8.B2                                                                                          27108123                 11.187704%

9. Information in relation to the person subject to the notification
obligation

2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)

 Ultimate controlling person      Name of controlled undertaking   % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                                                               than the notifiable threshold
 Boaz Weinstein                   Saba Capital Management GP, LLC
 Saba Capital Management GP, LLC  Saba Capital Management, L.P.                                                                                                                                                            12.079949%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

11-Mar-2025

13. Place Of Completion

New York

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  HOLJTMLTMTMBMLA